Polymyositis and dermatomyositis secondary prevention: Difference between revisions
Line 13: | Line 13: | ||
*** Abdomen CT scan | *** Abdomen CT scan | ||
*** Pelvic CT scan | *** Pelvic CT scan | ||
*** Gynecologic examination and pelvic/transvaginal ultrasonogram | |||
** It is controversial to use tumor markers as a screening test for malignancy. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 19:27, 11 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis secondary prevention On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis secondary prevention |
FDA on Polymyositis and dermatomyositis secondary prevention |
CDC on Polymyositis and dermatomyositis secondary prevention |
Polymyositis and dermatomyositis secondary prevention in the news |
Blogs on Polymyositis and dermatomyositis secondary prevention |
Risk calculators and risk factors for Polymyositis and dermatomyositis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- Effective measures for the secondary prevention of polymyositis and dermatomyositis include:
- Assessment for malignancy initially and annually for three years including:[1]
- Chest CT scan
- Abdomen CT scan
- Pelvic CT scan
- Gynecologic examination and pelvic/transvaginal ultrasonogram
- It is controversial to use tumor markers as a screening test for malignancy.
- Assessment for malignancy initially and annually for three years including:[1]
References
- ↑ Tiniakou, Eleni; Mammen, Andrew L. (2015). "Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review". Clinical Reviews in Allergy & Immunology. 52 (1): 20–33. doi:10.1007/s12016-015-8511-x. ISSN 1080-0549.